For the year ending 2025-12-31, TEM made $1,271,789K in revenue. -$245,028K in net income. Net profit margin of -19.27%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total net revenue | 1,271,789 | 693,398 | ||
| Cost of revenues-Genomic | - | 243,467 | ||
| Cost of revenues-Diagnostics | 386,102 | - | ||
| Cost of revenues-Data And Services | - | 68,818 | ||
| Cost of revenues-Data And Applications | 87,790 | - | ||
| Technology research and development | 146,107 | 167,519 | ||
| Research and development | 172,924 | 149,325 | ||
| Selling, general and administrative | 731,738 | 755,351 | ||
| Total cost and operating expenses | 1,524,661 | 1,384,480 | ||
| Loss from operations | -252,872 | -691,082 | ||
| Interest income | 12,628 | 11,084 | ||
| Interest expense | 70,267 | 53,653 | ||
| Loss on debt extinguishment | -12,034 | - | ||
| Other income, net | 31,447 | 32,336 | ||
| Loss before benefit from (provision for) income taxes | -291,098 | -701,315 | ||
| Benefit from (provision for) income taxes | -51,684 | - | ||
| Losses from equity method investments | -5,614 | -4,228 | ||
| Provision for income taxes | - | 266 | ||
| Net (loss) income | -245,028 | -705,809 | ||
| Accretion of convertible preferred stock to redemption value | 0 | 0 | ||
| Dividends on series a, b,b-1,b-2,c, d, e, f, g,g-3,andg-4preferred shares | 0 | 39,347 | ||
| Cumulative undeclared dividends on series c preferred shares | 0 | 1,174 | ||
| Net loss attributable to common shareholders, basic | -245,028 | -746,330 | ||
| Basic EPS | -1.41 | -6.23 | ||
| Diluted EPS | -1.41 | -6.23 | ||
| Basic Average Shares | 174,264 | 119,849 | ||
| Diluted Average Shares | 174,264 | 119,849 | ||
Tempus AI, Inc. (TEM)
Tempus AI, Inc. (TEM)